Kai Beckmann

News • Chemistry

Merck Acquires Life Sciences Company Bio-Techne

Merck has agreed to acquire Bio-Techne in an all-cash deal valuing the company at approximately $11.3 billion.

News

Merck: Beckmann to Succeed Garijo as CEO

Kai Beckmann to succeed Belén Garijo as new Chairman of the Executive Board and CEO of Merck in May 2026.

News

Merck KGaA and Universal Display Link on OLEDS

Top-Feature

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

INOSIM GmbH

Predictive Simulation in Pharma Production

From Catalogue to Collaboration

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Merck KGaA